Erdal Tasci

17PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersWomen's studies (incl. girls' studies)Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 30, 2025
Drug Repurposing in Glioblastoma Using a Machine Learning-Based Hybrid Feature Selection Approach.

Erdal Tasci, Kevin Camphausen, Andra Valentina Krauze

|Nov 26, 2025
Serum p-Cresol and 7-HOCA Levels and Fatty Acid and Purine Metabolism Are Associated with Survival, Progression, and Molecular Classification in GB-Serum Proteome and Metabolome Analysis Pre vs. Post Up-Front Chemoirradiation.

Andra V Krauze, M Li, Y Zhao

|May 14, 2025
GLIO-Select: Machine Learning-Based Feature Selection and Weighting of Tissue and Serum Proteomic and Metabolomic Data Uncovers Sex Differences in Glioblastoma.

Erdal Tasci, Shreya Chappidi, Ying Zhuge

|Oct 26, 2024
MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in Glioblastoma.

Erdal Tasci, Michael Popa, Ying Zhuge

|Aug 10, 2024
Correction: Tasci et al. RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma. Cancers 2023, 15, 2672.

Erdal Tasci, Sarisha Jagasia, Ying Zhuge

|Aug 10, 2024
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma.

Thomas Joyce, Erdal Tasci, Sarisha Jagasia

Pageof 3

Frequent Collaborators

15 joint publications

Andra Valentina Krauze

2 joint publications

Mary Sproull

2 joint publications

Harpreet Kaur

1 joint publications

M Li